Phase 1 Hodgkins Lymphoma Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
B-cell Non-Hodgkins Lymphoma (B-NHL)
Regeneron Pharmaceuticals91 enrolled20 locationsNCT05685173
Recruiting
Phase 1Phase 2
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more
Ossium Health, Inc.12 enrolled9 locationsNCT05589896
Not Yet Recruiting
Phase 1
Safety of Immune Cells for Patients with Relapsed Leukaemia or Lymphoma after Chemotherapy
Acute Lymphoblastic LeukaemiaNon-Hodgkins LymphomaChronic Lymphocytic Leukaemia
Western Sydney Local Health District, Westmead Hospital20 enrolled11 locationsACTRN12619000079145
Recruiting
Phase 1
Safety of Immune Cells for Patients with Relapsed Leukaemia or Lymphoma after Bone Marrow Transplant
Acute Lymphoblastic LeukaemiaNon-Hodgkins LymphomaChronic Lymphocytic Leukaemia
Western Sydney Local Health District, Westmead Hospital20 enrolled3 locationsACTRN12617001579381